Division of Joint surgery and Sports Medicine, Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
BMC Musculoskelet Disord. 2023 Oct 27;24(1):847. doi: 10.1186/s12891-023-06979-6.
There has been ongoing debate about the use of tourniquets in total knee arthroplasty, and their application is widely studied. A comprehensive understanding of the advantages and disadvantages of tourniquet use during the procedure is crucial for optimizing surgical outcomes. This study aimed to investigate the effectiveness of tourniquet application, with a particular focus on blood loss and perioperative complications, providing valuable insights for clinical practice.
Fifty patients who underwent total knee arthroplasty were randomized into tourniquet (n = 25) and nontourniquet (n = 25) groups. The same surgeon performed all surgical procedures. The follow-up time was 14 days after surgery. Primary outcomes were hemoglobin level changes, blood loss, operation time, and perioperative plasma D-dimer levels. Secondary outcomes were postoperative complications, including thrombotic and nonthrombotic events.
No significant differences were found in drainage, calculated blood loss, total blood loss, postoperative hemoglobin levels, or blood transfusion between the two groups (P > 0.05). No differences in D-dimer levels were observed on postoperative Days 1, 3, and 14 between the two groups, except on postoperative Day 7, when the D-dimer level in the tourniquet group was lower than that in the nontourniquet group (P = 0.03). The incidence of local complications (thigh bruising, blisters, pain, fat liquefaction, and superficial infections) in the tourniquet group was significantly higher than that in the nontourniquet group (P = 0.03), but no significant differences were found in thromboembolic and nonthromboembolic events or overall complications (P > 0.05).
We conclude that tourniquet use does not reduce the length of surgery or blood loss but does increase local complications in total knee arthroplasty.
在全膝关节置换术中,一直存在关于使用止血带的争论,其应用广泛。全面了解手术过程中使用止血带的优缺点对于优化手术效果至关重要。本研究旨在调查止血带应用的效果,特别是在失血和围手术期并发症方面,为临床实践提供有价值的见解。
50 例接受全膝关节置换术的患者被随机分为止血带(n=25)和非止血带(n=25)组。所有手术均由同一位外科医生完成。术后随访时间为 14 天。主要结局是血红蛋白水平变化、失血量、手术时间和围手术期血浆 D-二聚体水平。次要结局是术后并发症,包括血栓和非血栓事件。
两组在引流、计算失血量、总失血量、术后血红蛋白水平或输血方面无显著差异(P>0.05)。两组患者术后第 1、3、14 天 D-二聚体水平无差异,除术后第 7 天止血带组 D-二聚体水平低于非止血带组(P=0.03)。止血带组局部并发症(大腿瘀伤、水疱、疼痛、脂肪液化和浅表感染)的发生率明显高于非止血带组(P=0.03),但血栓栓塞和非血栓栓塞事件或总并发症发生率无显著差异(P>0.05)。
我们的结论是,使用止血带不会减少手术时间或失血量,但会增加全膝关节置换术中的局部并发症。